Conflicts of Interest in Psychopharmacology Textbooks.

Lisa Cosgrove, Farahdeba Herrawi, Allen F Shaughnessy

Abstract read

In one paragraph

Article in Community mental health journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Rebalancing commercial and public interests in prioritizing biomedical, social and environmental aspects of health through defining and managing conflicts of interest.Frontiers in medicine · 2023
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lisa CosgroveCounseling Psychology Department, Applied Ethics Center, University of Massachusetts-Boston, 100 William T Morrissey Blvd, Boston, USA. Lisa.cosgrove@umb.edu.ORCID 0000-0003-3101-5726

Farahdeba HerrawiCounseling Psychology Department, Applied Ethics Center, University of Massachusetts-Boston, 100 William T Morrissey Blvd, Boston, USA.

Allen F ShaughnessyDepartment of Family Medicine, Tufts University School of Medicine, 195 Canal Street, Malden, MA, 02148, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While most medical journals require disclosures of industry payments to authors and editors, there is no requirement for textbooks. In this study we evaluated nine well-known psychopharmacology textbooks to identify payments to their writers and editors. Two-thirds of the textbooks had at least one editor or author who received personal payments from one or more pharmaceutical companies, for a total of 11,021,409 USD paid to 11 of 21 editors/authors over a seven-year period. Much of this money was paid to a single author but 24% of the writers received over 75,000 USD each over this time period. There are several psychopharmacology textbooks authored by writers without apparent financial conflicts of interest. Just as with medical journals, medical textbooks should be transparent about payments made to their authors and editors.

Indexed as

Conflict of InterestPsychopharmacologyDisclosureHumansConflict of interestDisclosureMedical education/textbooksPharmaceutical industryPsychopharmacology

Identifiers

PMID34748149

DOI10.1007/s10597-021-00906-6

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.